Share class: Mankind Pharma Limited

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 41,25,78,527 9,42,03,558 ( 22.83 %) 0 22.83 %

Major shareholders: Mankind Pharma Limited

NameEquities%Valuation
Juneja Ramesh Family Trust
20.2 %
8,33,52,652 20.2 % 2 258 M ₹
Juneja Rajeev Family Trust
19.37 %
7,99,30,520 19.37 % 2 165 M ₹
Sheetal Prem Family Trust
14.97 %
6,17,55,635 14.97 % 1 673 M ₹
4.672 %
1,92,77,647 4.672 % 522 M ₹
2.796 %
1,15,33,906 2.796 % 312 M ₹
2.559 %
1,05,57,626 2.559 % 286 M ₹
SBI Life Insurance Co. Ltd. (Investment Portfolio)
2.389 %
98,55,974 2.389 % 267 M ₹
Beige Ltd.
1.984 %
81,85,333 1.984 % 222 M ₹
1.976 %
81,54,463 1.976 % 221 M ₹
1.662 %
68,55,990 1.662 % 186 M ₹
░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Other56.53%
Individuals18.16%
Institutional14.22%
Unknown11.09%

Based on 1000 largest holdings

Geographical origin of shareholders

India
65.51%
Individuals
18.16%
Mauritius
1.98%
Norway
1.56%
Singapore
1.02%
United Kingdom
0.37%
Hong Kong
0.12%
Sweden
0.11%
China
0.03%
Ireland
0.02%
Denmark
0.01%
Indonesia
0.01%

Based on 1000 largest holdings

Logo Mankind Pharma Limited
Mankind Pharma Limited is an India-based pharmaceutical company. It is engaged in developing, manufacturing, and marketing a range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It offers healthcare solutions for a range of healthcare needs with a portfolio that includes anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/ central nervous system, vitamins, minerals and nutrients and respiratory therapies. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others. Its branded product portfolio spans women’s health, fertility and critical care, with several brands in their respective therapy areas. Its subsidiaries include Lifestar Pharma Private Limited, Magnet Labs Private Limited, Jaspack Industries Private Limited, and others.
Employees
19,540
More about the company